(Seek Help) Long Term Luminal A BC transformed into TNBC (Surgery done and under chemo)

  • 6 replies
  • 287 subscribers
  • 162 views

Hi everyone who sees this post. I am posting this for my mom's circumstance. She has been diagnosed with breast cancer since 2007, which was luminal A category. She had reoccurance in 2016 and has been living as a metastasis patient since then with hormone therapy. Recently she has been newly diagnosed with a TNBC cancer in her left breast and she had undergo surgery to remove the left breast. I want to post her history and medical diagnosis here to seek instruction or help from the community. As her only family member and who just started working, I feel helpless. I would appreciate any advice from professionals and experienced patients. Also, I would like to help answer questions from whoever is finding my mom's treatment experience helpful.

Round pushpinI am especially concerned about what is our best practice to prevent her reoccurance and help her? Recently I can't help crying secretly in office seat. I want to try everything I can do to help her. I want her to take BRCA, HRD, PD-L1 tests. She argues that these tests are mainly for targeted therapy strategies and after she undergo all the chemotherapy things may already changed. Do you think we should take BRCA, HRD, PD-L1 tests of the sample? A big bow to whoever is willing to share something with me under the post. Bow♀️

The comprehensive review from 2007 to 2025 here:

Medical History from 2007

  • 18 years ago: The patient underwent "Left breast-conserving surgery + axillary lymph node dissection (ALND)" due to left breast cancer. Postoperative pathology indicated Invasive Ductal Carcinoma (IDC), no axillary lymph node metastasis, Luminal A subtype. Postoperative treatment included 6 cycles of CEF chemotherapy, radiotherapy to the left breast, followed by Tamoxifen for 5 years.
  • 2016: A metastatic lesion was identified in the right pubis. The patient underwent "Resection of the superior pubic ramus" at Shanghai Ninth People's Hospital. Pathology confirmed Metastatic Invasive Ductal Carcinoma. Immunohistochemistry (IHC): ER (++), PR (++), HER2 (-), Ki-67 (5%+), Luminal A subtype. Tamoxifen treatment was administered.
  • 2018: Disease progression occurred. Treatment was switched to Goserelin Acetate (Sustained-release Implant) in combination with Exemestane.
  • September 2023: Disease progression occurred. Treatment was updated to subcutaneous Goserelin Acetate (Sustained-release Implant) combined with Fulvestrant and Dalpiciclib.
  • September 2025: After 2 years of Dalpiciclib, drug resistance developed. Treatment with Abemaciclib was initiated. Zoledronic acid was administered for bone protection during this period.

Recent Surgery and Pathology (December 2025):

  • December 2, 2025: The patient underwent Left simple mastectomy due to a left breast mass.
  • Postoperative Pathology: Invasive Ductal Carcinoma (IDC), Grade II of the left breast. Tumor size: $1.6 * 1.5 * 1 cm. No lymphovascular invasion (LVI) identified. Nipple and skin were not involved.
  • Resection Margin/Cavity Assessment: No cancerous involvement found in the nipple, skin, surgical cavity, or base of the left breast.
  • Immunohistochemistry (IHC) (Report No. I25-05669): ER (-), PR (-), Ki-67 (30%+), HER2 Negative (-), p120 (Membranous +), E-Cad (+), CD34 (-), D2-40 (-).
  • Staging & Molecular Subtype: pT1cN0Mx, classified as TNBC (Triple-Negative Breast Cancer).
  • She's now taking AC chemotherapy and already finished the first chemo. Her doctor holds that after chemotherapy (we haven't decided how many rounds), the next step would be immunotherapy.

Would like to hear from you... Would like to answer questions...

  • Hello, I am so sorry to read this. The concern, love and care for your mum can be seen very clearly in your post. 
    I think that your questions focus on your mums TNBC diagnosis? There are lots of people on this forum with experience of treatments for this breast cancer type, and I am sure that they will come forward soon with much more informed replies than I can give you. Treatments for TNBC have advanced in recent years. There is much more available to oncologists than there was previously, and that gives hope. My limited understanding of targeted treatments is that oncologists will test for any relevant genes/mutations so as to administer the right treatment, at that time. Well, that is what I was told by my oncologist, but perhaps you could ask that question of your mums oncologist? Your mums response does suggest that she is quite well informed on this. And she is right that approaches are moving forward all the time, and that does inform things. 
    Hopefully someone with more knowledge than myself will come forward soon. X 

  • I have metastatic TNBC, PD-L1 positive. I have familiarity with UK treatment protocols. You mention Shanghai, protocols worldwide may not be the same.

    You ask about BRCA, HRD, PD-L1.  In the UK, testing wouldn’t normally be done for genetic mutations such as BRCA 1/2 unless the patient was under 60 or had a strong family history of breast cancer. PD-L1 wouldn’t normally be tested unless the tumour was grade 3 and either greater than 2mm or with lymph node involvement, or with evidence of metastatic spread. This is because Pembrolizumab only has 2 treatment authorisations for breast cancer the UK - one for metastatic PD-L1 positive TNBC, and 1 for neoadjuvant treatment of higher risk early stage PD-L1 positive TNBC tumours, as described above. 

    Reading what you have written, I think treatment in the UK would likely be 4 cycles of EC and 4 cycles of Paclitaxel (12 weeks). The UK more commonly uses epirubicin (the E in EC) rather than Adriamycin (the A) but they are very similar drugs. So your mum’s treatment looks to be what I would expect. You mention she might move onto targeted therapy but the targeted therapies used in ER+ and HER+ cancers don’t work on TNBC. 

  • Thank you for all the kind words. I really appreciate. My mom's such a strong and brave woman that I would admire her in my whole life. I just hope I can do something for her, for example maybe English forum has more information I could gather. I made a mistake in the previous post which I now corrected. My mom would probably proceed to immunotherapy rather than targeted therapy after chemo, according to her doctor. Yes we all need to hold hope. I will keep hunting. Thank you for your voice. I also hope everything good will happen for you as well.

  • Hi I want to thank you for all the information you shared, which I appreciate so much. I hope you are doing all great and will have a swift recovery soon. I know if you are positive in PD-L1 you can use tailored K medicine. I hope that is helping you powerfully. This is also why I have such concern of taking gene tests or not. I am thinking if she's diagnosed with specific type she may have more tailored treatment. I made a typo in the previous post and now have corrected it. My mom's going to undergo immunotherapy rather that targeted therapy according to her doctor, after chemo. I also heard TNBC patients are not necessarily avoiding targeted therapy, which depends on further results of gene tests.

    My mom's white blood cell count dropped to around 2.x after her first chemotherapy session. The doctor gave her a G-CSF injection to boost it. I’m a bit worried about the potential impact on her bone marrow, so I’m planning to focus heavily on her diet, hoping to raise her WBC naturally through nutrition. The doctor hasn't given us a fixed chemo schedule yet. I suspect he wants to stay flexible since there's no guarantee how effective the AC protocol will be for her. We may need to dynamically adapt. 

  • Immunotherapy such as pembro can work very well. It can also cause significant damage to healthy organs if the immune system reacts highly to it. Sort of good and bad together. I achieved remission but also had an acute kidney injury, lost my thyroid function and got lung damage. As a metastatic patient it was really my only hope - but on a just in case basis, the decision isn’t so straightforward. Wishing her, and you, well. 

    I had the G-CSF stimulators alongside EC. Caused a lot of bone pain but keeps my neutrophil count high. 

  • Hi I am very happy to hear you achieved remission! while so sorry for the unexpected damage to your other organs. I appreciate your advice, indeed this is a decision worth considering over and over. I will do my investigation and be conscious with my mom's choice. 

    That is exactly part of reason why I want to try my best to avoid G-CSF in the future. It's kind like overdraft. Also I heard it may cause Myelosuppression.